|
|
|
|
| LEADER |
00000cam a22000003 4500 |
| 001 |
EBOOKCENTRAL_ocn931803866 |
| 003 |
OCoLC |
| 005 |
20240329122006.0 |
| 006 |
m o d |
| 007 |
cr un||||||||| |
| 008 |
151208s2015 xx ob 001 0 eng d |
| 040 |
|
|
|a YDXCP
|b eng
|e pn
|c YDXCP
|d IDEBK
|d N$T
|d OPELS
|d UIU
|d OCLCF
|d EBLCP
|d CDX
|d OCLCQ
|d DEBBG
|d MERUC
|d D6H
|d OCLCQ
|d CUY
|d ZCU
|d ICG
|d DKC
|d OCLCQ
|d OCLCO
|d OCLCQ
|d OCLCO
|d OCLCL
|
| 066 |
|
|
|c (S
|
| 019 |
|
|
|a 930489597
|a 932333839
|
| 020 |
|
|
|a 9780128039465
|q (electronic bk.)
|
| 020 |
|
|
|a 0128039469
|q (electronic bk.)
|
| 020 |
|
|
|z 9780128039083
|
| 020 |
|
|
|z 0128039086
|
| 029 |
1 |
|
|a AU@
|b 000057012510
|
| 029 |
1 |
|
|a GBVCP
|b 879386207
|
| 035 |
|
|
|a (OCoLC)931803866
|z (OCoLC)930489597
|z (OCoLC)932333839
|
| 037 |
|
|
|a 875343
|b MIL
|
| 050 |
|
4 |
|a QP752.P62
|
| 072 |
|
7 |
|a MED
|x 075000
|2 bisacsh
|
| 072 |
|
7 |
|a SCI
|x 036000
|2 bisacsh
|
| 082 |
0 |
4 |
|a 612/.01577
|2 23
|
| 049 |
|
|
|a UAMI
|
| 245 |
0 |
4 |
|a The enzymes.
|
| 260 |
|
|
|b Academic Pr
|c 2015.
|
| 300 |
|
|
|a 1 online resource
|
| 336 |
|
|
|a text
|b txt
|2 rdacontent
|
| 337 |
|
|
|a computer
|b c
|2 rdamedia
|
| 338 |
|
|
|a online resource
|b cr
|2 rdacarrier
|
| 490 |
1 |
|
|a The enzymes ;
|v volume 38
|
| 505 |
8 |
|
|6 880-01
|a 4.1. Characteristics4.2. Involvement of Atherosclerosis; 4.3. Involvement in Asthma; 5. Conclusion; References; Chapter Two: Intracellular PAF-Acetylhydrolase Type I; 1. Introduction and History; 2. Identification of Intracellular PAF-AH, Isoform Ib; 3. Nomenclature of PAF-AH Ib Subunits; 4. Structure of PAF-AH Ib; 4.1. Structure of the Catalytic Subunits; 4.2. Structure of the Noncatalytic Subunit; 5. Physiological Roles of PAF-AH Ib; 5.1. Neuronal Development and Function; 5.2. Interaction Between PAF-AH Ib and the Reelin Signaling Pathway; 5.3. Spermatogenesis; 5.4. Cancer.
|
| 505 |
8 |
|
|a 5.5. Other Cellular Processes that Possibly Involve PAF-AH Ib6. Remaining Questions and Future Prospects; Acknowledgments; References; Chapter Three: Platelet-Activating Factor Acetylhydrolase and Brain Development; 1. Introduction; 2. Genetics of Human Lissencephaly and Recognition of the LIS1-Encoded Protein as PAFAH1B1; 3. Role of Pafah1b and Platelet-Activating Factor in Brain Development; 4. Coordination of Brain Platelet-Activating Factor Acetylhydrolase Signaling and Reelin Signaling in Mouse Brain.
|
| 505 |
8 |
|
|a 5. Roles of ""Brain"" Platelet-Activating Factor Acetylhydrolase in Testicular Development and Spermatogenesis6. Conclusions; References; Chapter Four: Intracellular Platelet-Activating Factor Acetylhydrolase, Type II: A Unique Cellular Phospholipase A2 That ... ; 1. Introduction; 2. Structure of PAF-AH (II); 3. Substrate Specificity of PAF-AH (II); 4. Biological Roles of PAF-AH (II); 5. Regulation of PAF-AH (II); 6. Future Prospects; Acknowledgments; References; Chapter Five: Trafficking and Oligomeric Regulation of Platelet-Activating Factor Acetylhydrolase Type II; 1. Introduction.
|
| 505 |
8 |
|
|a 1.1. PAFAH Family1.2. Oxidative Stress; 1.3. PAFAH-II as a Transacetylase; 1.4. Homology Model of PAFAH-II; 2. Trafficking of PAFAH-II; 2.1. Previous Research; 2.2. Recent Discovery; 3. Oligomeric Regulation of PAFAH-II; 4. Conclusions and Future Work; Acknowledgment; References; Chapter Six: Plasma PAF-AH (PLA2G7): Biochemical Properties, Association with LDLs and HDLs, and Regulation of Expression; 1. Introduction and Perspectives; 2. Biochemical Properties of Plasma PAF-AH; 2.1. Generalities; 2.2. Substrate Specificity; 2.3. Susceptibility to Oxidation; 3. Association with Lipoproteins.
|
| 504 |
|
|
|a Includes bibliographical references at the end of each chapters and indexes.
|
| 590 |
|
|
|a ProQuest Ebook Central
|b Ebook Central Academic Complete
|
| 650 |
|
0 |
|a Platelet activating factor.
|
| 650 |
|
2 |
|a Platelet Activating Factor
|
| 650 |
|
6 |
|a Facteur d'activation des plaquettes.
|
| 650 |
|
7 |
|a MEDICAL
|x Physiology.
|2 bisacsh
|
| 650 |
|
7 |
|a SCIENCE
|x Life Sciences
|x Human Anatomy & Physiology.
|2 bisacsh
|
| 650 |
|
7 |
|a Platelet activating factor
|2 fast
|
| 720 |
|
|
|a Tamanoi, Fuyuhiko
|4 edt
|
| 720 |
|
|
|a Stafforini, Diana
|4 edt
|
| 720 |
|
|
|a Inoue, Keizo
|4 edt
|
| 758 |
|
|
|i has work:
|a The Enzymes (Text)
|1 https://id.oclc.org/worldcat/entity/E39PCFtDcRhdtqK4R6grMbHmr3
|4 https://id.oclc.org/worldcat/ontology/hasWork
|
| 776 |
0 |
8 |
|i Print version:
|t Enzymes.
|d Academic Pr 2015
|z 9780128039083
|z 0128039086
|w (OCoLC)919106113
|
| 830 |
|
0 |
|a Enzymes ;
|v v. 38.
|
| 856 |
4 |
0 |
|u https://ebookcentral.uam.elogim.com/lib/uam-ebooks/detail.action?docID=4179432
|z Texto completo
|
| 880 |
0 |
|
|6 505-01/(S
|a Front Cover; Platelet-Activating Factor Acetylhydrolases (PAF-AH); Copyright; Contents; Contributors; Preface; Chapter One: Overview of PAF-Degrading Enzymes; 1. Introduction; 2. Intracellular PAF-AH I; 2.1. Characteristics; 2.2. Brain Development; 2.3. Spermatogenesis; 2.4. Aβ Generation and Secretion; 2.5. Cancer Pathogenicity; 2.6. Protein Trafficking and Sorting; 2.7. Aspirin Metabolism; 3. Intracellular PAF-AH II; 3.1. Characteristics; 3.2. Protective Role Against Oxidative Stress; 3.3. Epidermal Morphogenesis; 3.4. Transacetylation from PAF to Other Lipid Mediators; 4. Plasma PAF-AH.
|
| 938 |
|
|
|a Coutts Information Services
|b COUT
|n 33281120
|
| 938 |
|
|
|a EBL - Ebook Library
|b EBLB
|n EBL4179432
|
| 938 |
|
|
|a EBSCOhost
|b EBSC
|n 1103012
|
| 938 |
|
|
|a ProQuest MyiLibrary Digital eBook Collection
|b IDEB
|n cis33281120
|
| 938 |
|
|
|a YBP Library Services
|b YANK
|n 12733696
|
| 938 |
|
|
|a YBP Library Services
|b YANK
|n 12588947
|
| 994 |
|
|
|a 92
|b IZTAP
|
